Gian Paolo Spinelli

7PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Impact of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy on pCR and Tumor Downstaging in Resectable Gastric Cancer: A Meta-Analysis.

|Jul 12, 2025
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis.

Leonardo Brunetti, Valentina Santo, Alessandro Galletti

|Apr 30, 2021
Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors.

Lucrezia Raimondi, Filippo Maria Raimondi, Marta Pietranera

|Apr 30, 2021
Concomitant Mutations G12D and G13D on the Exon 2 of the KRAS Gene: Two Cases of Women with Colon Adenocarcinoma.

Elena De Falco, Luca Pacini, Daniela Bastianelli

|Feb 05, 2021
Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review.

Lucrezia Raimondi, Filippo Maria Raimondi, Luigi Rossi

|Sep 23, 2020
PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer.

Lucrezia Raimondi, Filippo Maria Raimondi, Laura Di Benedetto

Pageof 2

Frequent Collaborators

3 joint publications

Lucrezia Raimondi

1 joint publications

Filippo Maria Raimondi

1 joint publications

Elena De Falco

1 joint publications

Evelina Miele